BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ondansetron

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

299+ PubMed studies analyzed · 95 RCTs · Evidence Score: 60.2

Research Domains

Ondansetron has been studied across 16 research domains including 🌤️ Mood & Depression, 💊 Pain, 🔬 Oncology, 😴 Sleep, 🫁 Liver & Detox. The primary research focus is 🌤️ Mood & Depression with 29% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ondansetron, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Pregnanolone
16 shared targets
Etiocholanolone
16 shared targets
Ciprofloxacin
15 shared targets
Etomidate
16 shared targets
Bicuculline
16 shared targets
Androsterone
16 shared targets
Picrotoxin
14 shared targets
gamma-Aminobutyric
17 shared targets
Triiodothyronine
21 shared targets
Quipazine
11 shared targets
Loading evidence profile...

This evidence profile for Ondansetron is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.